{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:58:59Z","timestamp":1792198739030,"version":"4.4.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100005156","name":"Alexander von Humboldt-Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005156","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.ejphar.2013.09.032","type":"journal-article","created":{"date-parts":[[2013,9,25]],"date-time":"2013-09-25T04:03:24Z","timestamp":1380081804000},"page":"215-224","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":73,"title":["Drug\/drug interaction of common NSAIDs with antiplatelet effect of aspirin in human platelets"],"prefix":"10.1016","volume":"721","author":[{"given":"Aaruni","family":"Saxena","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishal M.","family":"Balaramnavar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Hohlfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil K.","family":"Saxena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2013.09.032_bib1","doi-asserted-by":"crossref","first-page":"4213","DOI":"10.1016\/j.bmcl.2009.05.120","article-title":"Design, synthesis and evaluation of aspirin analogues having an additional carboxylate substituent for antithrombotic activity","volume":"19","author":"Alagha","year":"2009","journal-title":"Bioorganic & Medicinal Chemistry Letters"},{"key":"10.1016\/j.ejphar.2013.09.032_bib2","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1002\/art.30175","article-title":"Low-dose naproxen interferes with the antiplatelet effects of aspirin in healthy subjects: recommendations to minimize the functional consequences","volume":"63","author":"Anzellotti","year":"2011","journal-title":"Arthtitis and Rheumatism"},{"key":"10.1016\/j.ejphar.2013.09.032_bib3","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2165\/00003088-199835040-00001","article-title":"Clinical pharmacokinetics of nimesulide","volume":"35","author":"Bernareggi","year":"1998","journal-title":"Clinical Pharmacokinetics"},{"key":"10.1016\/j.ejphar.2013.09.032_bib4","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1093\/eurheartj\/ehl334","article-title":"Systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease","volume":"27","author":"Biondi-Zoccai","year":"2006","journal-title":"European Heart Journal"},{"key":"10.1016\/j.ejphar.2013.09.032_bib5","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1096\/fj.05-5346com","article-title":"Inhibition of prostaglandin E2 synthesis by SC-560 is independent of cyclooxygenase 1 inhibition","volume":"20","author":"Brenneis","year":"2006","journal-title":"FASEB Journal"},{"key":"10.1016\/j.ejphar.2013.09.032_bib6","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.jacc.2005.01.045","article-title":"Pharmacodynamic interaction of naproxen with low-dose aspirin in healthy subjects","volume":"45","author":"Capone","year":"2005","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.ejphar.2013.09.032_bib7","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa003199","article-title":"Cyclooxygenase inhibitors and the antiplatelet effects of aspirin","volume":"345","author":"Catella-Lawson","year":"2001","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.ejphar.2013.09.032_bib8","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1365-2710.2004.00626.x","article-title":"Differences in the single-oral-dose pharmacokinetics and urinary excretion of paracetamol and its conjugates between Hong Kong Chinese and Caucasian subjects","volume":"30","author":"Critchley","year":"2005","journal-title":"Journal of Clinical Pharmacy and Therapeutics"},{"key":"10.1016\/j.ejphar.2013.09.032_bib9","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1056\/NEJMoa021778","article-title":"Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes","volume":"348","author":"Gaede","year":"2003","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.ejphar.2013.09.032_bib10","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/1074-5521(95)90050-0","article-title":"Molecular recognition of the inhibitor AG-1343 by HIV-1 protease: conformationally flexible docking by evolutionary programming","volume":"2","author":"Gehlhaar","year":"1995","journal-title":"Chemical Biology"},{"key":"10.1016\/j.ejphar.2013.09.032_bib11","doi-asserted-by":"crossref","unstructured":"Gehlhaar, D.K., Bouzida, D., Rejto, P.A., 1998. Fully automated and rapid flexible docking of inhibitors covalently bound to serine proteases in evolutionary programming VII. In: Proceedings of the Seventh International Conference on Evolutionary Programming. London, UK: Springer, pp. 449\u2013461.","DOI":"10.1007\/BFb0040797"},{"key":"10.1016\/j.ejphar.2013.09.032_bib12","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1177\/0091270007310379","article-title":"Effects of ibuprofen on the magnitude and duration of aspirin's inhibition of platelet aggregation: clinical consequences in stroke prophylaxis","volume":"48","author":"Gengo","year":"2008","journal-title":"Journal of Clinical Pharmacology"},{"key":"10.1016\/j.ejphar.2013.09.032_bib13","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.amjcard.2007.11.054","article-title":"The antiplatelet effect of six non-steroidal anti-inflammatory drugs and their pharmacodynamic interaction with aspirin in healthy volunteers","volume":"101","author":"Gladding","year":"2008","journal-title":"American Journal of Cardiology"},{"key":"10.1016\/j.ejphar.2013.09.032_bib14","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ejps.2008.10.015","article-title":"Kinetic modelling of NSAID action on COX-1: focus on in vitro\/in vivo aspects and drug combinations","volume":"36","author":"Goltsov","year":"2009","journal-title":"European Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.ejphar.2013.09.032_bib15","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0049-3848(93)90164-J","article-title":"Two-year follow-up of aspirin responder and aspirin non responder. A pilot-study including 180 post-stroke patients","volume":"71","author":"Grotemeyer","year":"1993","journal-title":"Thrombosis Research"},{"key":"10.1016\/j.ejphar.2013.09.032_bib16","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1538-7836.2007.02800.x","article-title":"Pyrazolinone analgesics prevent the antiplatelet effect of aspirin and preserve human platelet thromboxane synthesis","volume":"6","author":"Hohlfeld","year":"2008","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"10.1016\/j.ejphar.2013.09.032_bib17","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ahj.2009.11.033","article-title":"Hypothesis formulation from subgroup analyses: nonadherence or nonsteroidal anti-inflammatory drug use explains the lack of clinical benefit of aspirin on first myocardial infarction attributed to aspirin resistance","volume":"159","author":"Hennekens","year":"2010","journal-title":"American Heart Journal"},{"key":"10.1016\/j.ejphar.2013.09.032_bib18","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1023\/A:1015803803650","article-title":"Pharmacokinetics of ketorolac and p-hydroxyketorolac following oral and intramuscular administration of ketorolac tromethamine","volume":"6","author":"Jung","year":"1989","journal-title":"Pharmaceutical Research"},{"key":"10.1016\/j.ejphar.2013.09.032_bib19","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/0090-6980(82)90123-X","article-title":"Indomethacin prevents the long-lasting inhibitory effect of aspirin on human platelet cyclo-oxygenase activity","volume":"23","author":"Livio","year":"1982","journal-title":"Prostaglandins"},{"key":"10.1016\/j.ejphar.2013.09.032_bib20","doi-asserted-by":"crossref","first-page":"7330","DOI":"10.1021\/bi952776w","article-title":"Synthesis and use of iodinated nonsteroidal antiinflammatory drug analogs as crystallographic probes of the prostaglandin H2 synthase cyclooxygenase active site","volume":"35","author":"Loll","year":"1996","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejphar.2013.09.032_bib21","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/nsb1196-927","article-title":"Flexibility of the NSAID binding site in the structure of human cyclooxygenase-2","volume":"3","author":"Luong","year":"1996","journal-title":"Natural Structural Biology"},{"key":"10.1016\/j.ejphar.2013.09.032_bib22","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1055\/s-0038-1657677","article-title":"Variable platelet response to low-dose ASA and the risk of limb deterioration in patients submitted to peripheral arterial angioplasty","volume":"78","author":"Mueller","year":"1997","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1016\/j.ejphar.2013.09.032_bib23","doi-asserted-by":"crossref","first-page":"14583","DOI":"10.1073\/pnas.251543298","article-title":"A high level of cyclooxygenase-2 inhibitor selectivity is associated with a reduced interference of platelet cyclooxygenase-1 inactivation by aspirin","volume":"98","author":"Ouellet","year":"2001","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.ejphar.2013.09.032_bib24","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/(SICI)1099-081X(199608)17:6<511::AID-BDD969>3.0.CO;2-Y","article-title":"The effect of food on the bioavailability of ibuprofen and flurbiprofen from sustained release formulations","volume":"17","author":"Pargal","year":"1996","journal-title":"Biopharmaceutics and Drug Disposition"},{"key":"10.1016\/j.ejphar.2013.09.032_bib25","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/367243a0","article-title":"The X-ray crystal structure of the membrane protein prostaglandin H2 synthase-1","volume":"367","author":"Picot","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2013.09.032_bib26","first-page":"246","article-title":"Comparative pharmacokinetic analysis of a novel sustained-release dosage form of diclofenac sodium in healthy subjects","volume":"26","author":"Raz","year":"1988","journal-title":"International Journal of Clinical Pharmacology, Therapy, and Toxicology"},{"key":"10.1016\/j.ejphar.2013.09.032_bib27","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.clpt.2006.05.004","article-title":"Celecoxib, ibuprofen, and the antiplatelet effect of aspirin in patients with osteoarthritis and ischemic heart disease","volume":"80","author":"Renda","year":"2006","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.ejphar.2013.09.032_bib28","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/sj.bjp.0701076","article-title":"Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor","volume":"121","author":"Riendeau","year":"1997","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.ejphar.2013.09.032_bib29","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1073\/pnas.0909765106","article-title":"Coxibs interfere with the action of aspirin by binding tightly to one monomer of cyclooxygenase-1","volume":"107","author":"Rimon","year":"2009","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.ejphar.2013.09.032_bib30","doi-asserted-by":"crossref","first-page":"e 25790","DOI":"10.1371\/journal.pone.0025790","article-title":"The atypical stimulant and nootropic modafinil interacts with the dopamine transporter in a different manner than classical cocaine-like inhibitors","volume":"6","author":"Schmitt","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2013.09.032_bib31","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1111\/j.1476-5381.2009.00243.x","article-title":"The interaction of ibuprofen and diclofenac with aspirin in healthy volunteers","volume":"157","author":"Schuijt","year":"2009","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.ejphar.2013.09.032_bib32","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1023\/A:1008202821328","article-title":"Differential evolution\u2014a simple and efficient adaptive scheme for global optimization over continuous spaces","volume":"11","author":"Storn","year":"1997","journal-title":"Journal of Global Optimization"},{"key":"10.1016\/j.ejphar.2013.09.032_bib33","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nrrheum.2011.75","article-title":"Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE","volume":"7","author":"Symmons","year":"2011","journal-title":"Nature Reviews Rheumatology"},{"key":"10.1016\/j.ejphar.2013.09.032_bib34","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1021\/jm051197e","article-title":"MolDock: a new technique for high-accuracy molecular docking","volume":"49","author":"Thomsen","year":"2006","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.ejphar.2013.09.032_bib35","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/095371000403125","article-title":"Habitual smoking causes an abnormality in platelet thromboxane A2 metabolism and results in an altered susceptibility to aspirin effects","volume":"11","author":"Weber","year":"2000","journal-title":"Platelets"},{"key":"10.1016\/j.ejphar.2013.09.032_bib36","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1172\/JCI23683","article-title":"Differential impact of prostaglandin H synthase 1 knockdown on platelets and parturition","volume":"5","author":"Yu","year":"2005","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.ejphar.2013.09.032_bib37","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/j.1552-4604.1998.tb04469.x","article-title":"Single- and multiple-dose pharmacokinetic comparison of a sustained-release tablet and conventional tablets of naproxen in healthy volunteers","volume":"38","author":"Zhou","year":"1998","journal-title":"Journal of Clinical Pharmacology"},{"key":"10.1016\/j.ejphar.2013.09.032_bib38","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1161\/01.CIR.0000081770.51929.5A","article-title":"Functional and biochemical evaluation of platelet aspirin resistance after coronary artery bypass surgery","volume":"108","author":"Zimmermann","year":"2003","journal-title":"Circulation"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299913006857?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299913006857?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:18:26Z","timestamp":1757974706000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299913006857"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":38,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0014299913006857"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2013.09.032","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug\/drug interaction of common NSAIDs with antiplatelet effect of aspirin in human platelets","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2013.09.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}